Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
IRFEN Junior Susp 100 mg/5ml Fl 200 ml
Drug
Irfen Junior, Suspension
Antiphlogistikum, Analgetikum, Antipyretikum
07.10.1. – simple antiinflammatories
HAM – Human medicine
SUOR – Oral suspension
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/7/2018
12/31/9999
Dosage strength
Irfen Junior, Suspension
Antiphlogistikum, Analgetikum, Antipyretikum
01
Z – approved
Package
7680669330019
In trade from / since 12/7/2018
A/R – Authorised / referenced
200 ml
001
Z – approved
Declaration
Component
100 mg ibuprofenum
acidum citricum
xanthani gummi
hypromellosum
glycerolum
natrii chloridum
polysorbatum 80
aromatica
alcohol benzylicus
vanillinum
natrii cyclamas
2 g maltitolum liquidum
acesulfamum kalicum
sucralosum
10 mg natrii benzoas
aqua
7.375 mg natrium
xanthani gummi
hypromellosum
glycerolum
natrii chloridum
polysorbatum 80
aromatica
alcohol benzylicus
vanillinum
natrii cyclamas
2 g maltitolum liquidum
acesulfamum kalicum
sucralosum
10 mg natrii benzoas
aqua
7.375 mg natrium
Spezialitätenliste***
SL
-
-
13.55
None
Yes
10%
Yes
Authorisation holder
7601001396685
Mepha Pharma AG
Kirschgartenstrasse 14
4051 Basel (BS)
Kirschgartenstrasse 14
4051 Basel (BS)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.